GTBIF
Price
$7.13
Change
+$0.15 (+2.15%)
Updated
Aug 8 closing price
Capitalization
1.7B
VEXTF
Price
$0.17
Change
+$0.01 (+6.25%)
Updated
Aug 8 closing price
Capitalization
42.36M
Interact to see
Advertisement

GTBIF vs VEXTF

Header iconGTBIF vs VEXTF Comparison
Open Charts GTBIF vs VEXTFBanner chart's image
Green Thumb Industries
Price$7.13
Change+$0.15 (+2.15%)
Volume$601.51K
Capitalization1.7B
Vext Science
Price$0.17
Change+$0.01 (+6.25%)
Volume$95.91K
Capitalization42.36M
GTBIF vs VEXTF Comparison Chart in %
Loading...
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VEXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GTBIF vs. VEXTF commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTBIF is a Hold and VEXTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (GTBIF: $7.13 vs. VEXTF: $0.17)
Brand notoriety: GTBIF and VEXTF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GTBIF: 121% vs. VEXTF: 190%
Market capitalization -- GTBIF: $1.97B vs. VEXTF: $50.39M
GTBIF [@Pharmaceuticals: Generic] is valued at $1.97B. VEXTF’s [@Pharmaceuticals: Generic] market capitalization is $50.39M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $66.04B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GTBIF’s FA Score shows that 1 FA rating(s) are green whileVEXTF’s FA Score has 1 green FA rating(s).

  • GTBIF’s FA Score: 1 green, 4 red.
  • VEXTF’s FA Score: 1 green, 4 red.
According to our system of comparison, VEXTF is a better buy in the long-term than GTBIF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GTBIF’s TA Score shows that 5 TA indicator(s) are bullish while VEXTF’s TA Score has 5 bullish TA indicator(s).

  • GTBIF’s TA Score: 5 bullish, 4 bearish.
  • VEXTF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both GTBIF and VEXTF are a good buy in the short-term.

Price Growth

GTBIF (@Pharmaceuticals: Generic) experienced а +5.63% price change this week, while VEXTF (@Pharmaceuticals: Generic) price change was +16.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.48%. For the same industry, the average monthly price growth was +8.38%, and the average quarterly price growth was +79.14%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.48% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GTBIF($1.7B) has a higher market cap than VEXTF($42.4M). GTBIF has higher P/E ratio than VEXTF: GTBIF (64.82) vs VEXTF (5.78). VEXTF YTD gains are higher at: 50.309 vs. GTBIF (-12.729). GTBIF has higher annual earnings (EBITDA): 368M vs. VEXTF (1.18M). GTBIF has more cash in the bank: 211M vs. VEXTF (4.83M). VEXTF has less debt than GTBIF: VEXTF (37.4M) vs GTBIF (526M). GTBIF has higher revenues than VEXTF: GTBIF (1.14B) vs VEXTF (39.2M).
GTBIFVEXTFGTBIF / VEXTF
Capitalization1.7B42.4M4,000%
EBITDA368M1.18M31,134%
Gain YTD-12.72950.309-25%
P/E Ratio64.825.781,122%
Revenue1.14B39.2M2,911%
Total Cash211M4.83M4,372%
Total Debt526M37.4M1,406%
FUNDAMENTALS RATINGS
GTBIF vs VEXTF: Fundamental Ratings
GTBIF
VEXTF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8896
PRICE GROWTH RATING
1..100
4636
P/E GROWTH RATING
1..100
1517
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VEXTF's Valuation (50) in the null industry is somewhat better than the same rating for GTBIF (84). This means that VEXTF’s stock grew somewhat faster than GTBIF’s over the last 12 months.

VEXTF's Profit vs Risk Rating (100) in the null industry is in the same range as GTBIF (100). This means that VEXTF’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's SMR Rating (88) in the null industry is in the same range as VEXTF (96). This means that GTBIF’s stock grew similarly to VEXTF’s over the last 12 months.

VEXTF's Price Growth Rating (36) in the null industry is in the same range as GTBIF (46). This means that VEXTF’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's P/E Growth Rating (15) in the null industry is in the same range as VEXTF (17). This means that GTBIF’s stock grew similarly to VEXTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GTBIFVEXTF
RSI
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VEXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VITNX106.440.70
+0.66%
Vanguard Instl Ttl Stk Mkt Idx I
TORYX56.550.34
+0.60%
Torray Fund
JVTSX76.850.15
+0.20%
Janus Henderson Venture S
JVSIX15.830.01
+0.06%
Janus Henderson Small-Mid Cap Value I
SMEYX16.27N/A
N/A
Invesco Small Cap Equity Y

GTBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBIF has been closely correlated with CURLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if GTBIF jumps, then CURLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBIF
1D Price
Change %
GTBIF100%
+2.15%
CURLF - GTBIF
82%
Closely correlated
+13.97%
TCNNF - GTBIF
82%
Closely correlated
+5.52%
VRNOF - GTBIF
79%
Closely correlated
+12.95%
TSNDF - GTBIF
77%
Closely correlated
+8.76%
CRLBF - GTBIF
71%
Closely correlated
+9.79%
More

VEXTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VEXTF has been loosely correlated with TCNNF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if VEXTF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VEXTF
1D Price
Change %
VEXTF100%
+6.92%
TCNNF - VEXTF
38%
Loosely correlated
+5.52%
CURLF - VEXTF
36%
Loosely correlated
+13.97%
GTBIF - VEXTF
34%
Loosely correlated
+2.15%
GLASF - VEXTF
31%
Poorly correlated
+3.97%
VRNOF - VEXTF
30%
Poorly correlated
+12.95%
More